Skip to main content
. 2019 Sep 13;77(1):58–64. doi: 10.1001/jamaneurol.2019.3238

Table 2. Rate Ratio of Multiple Sclerosis According to Within-Person Increase in sNfL.

Increase in sNfLa No. (%) RR (95% CI) P Valueb P Valuec
Cases Controls
Within-person increase from presymptomatic to postonset samples
≥5 pg/mL 16 (53.3) 10 (33.3) 2.25 (0.69-7.31) .18 .71
≥10 pg/mL 14 (46.7) 3 (10.0) 6.00 (1.34-26.81) .02 .08
≥15 pg/mL 14 (46.7) 3 (10.0) 6.00 (1.34-26.81) .02 .08
≥20 pg/mL 13 (43.3) 1 (3.3) 12.00 (1.56-92.29) .02 .07
Within-person increase in presymptomatic samples
≥5 pg/mL 19 (63.3) 6 (20.0) 7.50 (1.72-32.80) .007 .03
≥10 pg/mL 11 (36.7) 2 (6.7) 10.00 (1.28-78.12) .03 .11
≥15 pg/mL 7 (23.3) 1 (3.3) 11.25 (1.15-110.04)d .04d .15
≥20 pg/mL 6 (20.0) 1 (3.3) 9.03 (0.90-90.66)d .06d .25

Abbreviations: RR, rate ratio; sNfL, serum neurofilament light.

a

The categories are not mutually exclusive.

b

Raw P value.

c

P value adjusted for multiple comparisons using the Bonferroni correction.

d

Estimated using unconditional logistic regression owing to no discordant pairs in cases and matched controls that experienced an increase in sNfL. The model was adjusted for age, sex, and race/ethnicity.